阿泰生命科学 ATAI
美股生物科技
$0.00 +$0.00 (0.00%)
休市 · Nov 6, 9:30 am ET
开盘$0.00
昨收$0.00
当日区间$0.00 – $0.00
成交量0.00
市值–
市盈率（TTM）–
股息率–
ATAI 相关新闻
匹配 AtaiBeckley 或代码 ATAI 的头条新闻，按最新排序。
- News On AtaiBeckley Inc. (ATAI) Now Under LLY
- AtaiBeckley: AtaiBeckley Inc. - Cash Settlement/Acceleration of Expirations Option Symbol: ATAI
- H.C. Wainwright Maintains AtaiBeckley(ATAI.US) With Hold Rating, Maintains Target Price $7.5
- Analysts' Opinions Are Mixed on These Healthcare Stocks: Atai Beckley N.V. (ATAI), InspireMD (NSPR) and Silexion Therapeutics (SLXN)
- Oppenheimer Downgrades AtaiBeckley(ATAI.US) to Hold Rating 负面
- Deutsche Bank Downgrades AtaiBeckley(ATAI.US) to Hold Rating, Cuts Target Price to $8 负面
- AtaiBeckley: AtaiBeckley Inc. - Anticipated Cash Settlement Option Symbol: ATAI
- Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Definitive Healthcare Corp (DH) and Atai Beckley N.V. (ATAI)
- H.C. Wainwright Downgrades AtaiBeckley(ATAI.US) to Hold Rating, Cuts Target Price to $7.5 负面
- Berenberg Bank Downgrades AtaiBeckley(ATAI.US) to Hold Rating, Cuts Target Price to $7.45 负面
- Berenberg Bank Sticks to Their Buy Rating for Atai Beckley N.V. (ATAI)
- Maxim Group Maintains AtaiBeckley(ATAI.US) With Hold Rating
- Berenberg Bank Maintains AtaiBeckley(ATAI.US) With Buy Rating, Maintains Target Price $14
- TD Cowen Downgrades AtaiBeckley(ATAI.US) to Hold Rating 负面
- A Quick Look at Today's Ratings for AtaiBeckley(ATAI.US), With a Forecast Between $7.5 to $8
暂无评论——快来第一个聊聊 ATAI。
登录后参与讨论。